Colin O’Dowd Tablet Image Colin O’Dowd Mobile Image
Mobile Gradient

Colin O’Dowd

Colin O’Dowd Tablet Image Colin O’Dowd Mobile Image
Mobile Gradient

Colin O’Dowd

 

Colin O’Dowd

Colin manages the medicinal chemistry, ADMET and CADD groups within Almac Discovery bringing to bear his experience in chemistry contract research from his 9 year tenure in Almac Sciences.

Click to Read More

Colin has broad medicinal chemistry skills, he and his team have recently worked on Discovery’s kinase and deubiquitylating enzyme programs and platform. He was heavily involved in implementing and delivering the initial phases of the highly successful industry-academia research collaboration between Almac Discovery and Queen’s University Belfast which continues with the Center for Precision Therapeutics in 2016.

He has a Ph.D in synthetic organic chemistry from Queen’s University.

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies